Pulmonary involvement in newly diagnosed and untreated rheumatoid arthritis and psoriatic arthritis: a prospective longitudinal study
2025

Pulmonary Issues in New Rheumatoid and Psoriatic Arthritis Patients

Sample size: 50 publication 10 minutes Evidence: moderate

Author Information

Author(s): Lone Winter, Simon M. Petzinna, Dirk Skowasch, Carmen Pizarro, Marcel Weber, Daniel Kütting, Charlotte Behning, Claus-Jürgen Bauer, Valentin S. Schäfer

Primary Institution: University Hospital Bonn

Hypothesis

To longitudinally assess pulmonary involvement in newly diagnosed rheumatoid arthritis (RA) and psoriatic arthritis (PsA) patients over a 12-month follow-up.

Conclusion

The study highlights significant, mostly asymptomatic pulmonary involvement in newly diagnosed RA and PsA patients, indicating that reducing arthritis activity does not necessarily lessen pulmonary risks.

Supporting Evidence

  • 37.0% of arthritis patients exhibited radiographic pulmonary involvement.
  • 64.7% of patients with pulmonary involvement were asymptomatic.
  • Mean CRP levels significantly decreased in RA and PsA patients during follow-up.
  • Significant reductions in disease activity scores were observed.
  • No associations were identified between pulmonary function outcomes and disease activity.

Takeaway

Many people with rheumatoid arthritis and psoriatic arthritis have lung problems that they don't even know about. It's important to check their lungs regularly, even if they feel fine.

Methodology

Patients were examined with clinical assessments, pulmonary function tests, and chest radiography at three-month intervals for one year.

Potential Biases

Potential biases may arise from the observational nature of the study and the reliance on self-reported symptoms.

Limitations

The study had a relatively small sample size, which may limit the generalizability of the findings.

Participant Demographics

The study included 50 patients (26 RA, 24 PsA) with a gender distribution of 27 males and 23 females.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI: 9.9–37.1 for RA CRP levels; 95% CI: 5.7–20.9 for PsA CRP levels

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1007/s00296-024-05751-w

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication